4.69 USD
+0.01 (+0.21%)
4.69 USD
0 (0%)
DHC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 128 industry peers in the Diversified REITs industry. Both the profitability and financial health of DHC have multiple concerns. DHC does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year DHC has reported negative net income.
DHC had a positive operating cash flow in the past year.
DHC had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: DHC reported negative operating cash flow in multiple years.
1.2 Ratios
DHC has a Return On Assets of -7.52%. This is amonst the worse of the industry: DHC underperforms 87.50% of its industry peers.
DHC's Return On Equity of -20.85% is on the low side compared to the rest of the industry. DHC is outperformed by 82.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.52% | ||
| ROE | -20.85% | ||
| ROIC | N/A |
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of DHC (17.58%) is worse than 92.97% of its industry peers.
DHC's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for DHC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.58% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
2. Health
2.1 Basic Checks
DHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DHC has more shares outstanding
Compared to 5 years ago, DHC has more shares outstanding
Compared to 1 year ago, DHC has a worse debt to assets ratio.
2.2 Solvency
DHC has an Altman-Z score of -0.31. This is a bad value and indicates that DHC is not financially healthy and even has some risk of bankruptcy.
DHC has a worse Altman-Z score (-0.31) than 79.69% of its industry peers.
DHC has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.
DHC has a Debt to Equity ratio of 1.61. This is in the lower half of the industry: DHC underperforms 60.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.31 |
ROIC/WACCN/A
WACC6.26%
2.3 Liquidity
A Current Ratio of 6.66 indicates that DHC has no problem at all paying its short term obligations.
With an excellent Current ratio value of 6.66, DHC belongs to the best of the industry, outperforming 97.66% of the companies in the same industry.
A Quick Ratio of 6.66 indicates that DHC has no problem at all paying its short term obligations.
DHC's Quick ratio of 6.66 is amongst the best of the industry. DHC outperforms 97.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.66 | ||
| Quick Ratio | 6.66 |
3. Growth
3.1 Past
The earnings per share for DHC have decreased strongly by -22.32% in the last year.
Looking at the last year, DHC shows a small growth in Revenue. The Revenue has grown by 4.10% in the last year.
The Revenue has been growing slightly by 7.53% on average over the past years.
EPS 1Y (TTM)-22.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
Revenue 1Y (TTM)4.1%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%
3.2 Future
The Earnings Per Share is expected to grow by 13.97% on average over the next years. This is quite good.
DHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.93% yearly.
EPS Next Y-1%
EPS Next 2Y20.29%
EPS Next 3Y13.98%
EPS Next 5YN/A
Revenue Next Year4.4%
Revenue Next 2Y3.86%
Revenue Next 3Y3.93%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for DHC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHC. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
DHC's Enterprise Value to EBITDA ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 15.31 |
4.3 Compensation for Growth
A more expensive valuation may be justified as DHC's earnings are expected to grow with 13.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.29%
EPS Next 3Y13.98%
5. Dividend
5.1 Amount
With a yearly dividend of 0.85%, DHC is not a good candidate for dividend investing.
With a Dividend Yield of 0.85, DHC pays less dividend than the industry average, which is at 6.28. 91.41% of the companies listed in the same industry pay a better dividend than DHC!
Compared to an average S&P500 Dividend Yield of 1.96, DHC's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.85% |
5.2 History
The dividend of DHC decreases each year by -45.60%.
DHC has been paying a dividend for at least 10 years, so it has a reliable track record.
DHC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
DHC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-2.74%
EPS Next 2Y20.29%
EPS Next 3Y13.98%
4.69
+0.01 (+0.21%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners76.91%
Inst Owner Change-2.8%
Ins Owners0.47%
Ins Owner Change-8.52%
Market Cap1.14B
Revenue(TTM)1.54B
Net Income(TTM)-352.11M
Analysts74.29
Price Target5.36 (14.29%)
Short Float %2.6%
Short Ratio7.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.85% |
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-2.74%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-142.08%
Min EPS beat(2)-213.15%
Max EPS beat(2)-71.02%
EPS beat(4)1
Avg EPS beat(4)-46.14%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)2
Avg EPS beat(8)-24.79%
EPS beat(12)4
Avg EPS beat(12)-9.26%
EPS beat(16)4
Avg EPS beat(16)-20.93%
Revenue beat(2)1
Avg Revenue beat(2)0.09%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)0.67%
Revenue beat(4)2
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-0.49%
Max Revenue beat(4)1.32%
Revenue beat(8)2
Avg Revenue beat(8)-0.49%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)5
Avg Revenue beat(16)-0.71%
PT rev (1m)23.53%
PT rev (3m)40%
EPS NQ rev (1m)5.26%
EPS NQ rev (3m)7.69%
EPS NY rev (1m)-27.27%
EPS NY rev (3m)-41.89%
Revenue NQ rev (1m)1.2%
Revenue NQ rev (3m)1.04%
Revenue NY rev (1m)0.71%
Revenue NY rev (3m)0.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.74 | ||
| P/FCF | N/A | ||
| P/OCF | 60.77 | ||
| P/B | 0.67 | ||
| P/tB | 0.67 | ||
| EV/EBITDA | 15.31 |
EPS(TTM)-1.37
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)0.08
OCFY1.65%
SpS6.35
BVpS6.97
TBVpS6.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.52% | ||
| ROE | -20.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.58% | ||
| FCFM | N/A |
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 11.41 | ||
| Cap/Depr | 65.29% | ||
| Cap/Sales | 11.78% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 7.83% | ||
| Profit Quality | N/A | ||
| Current Ratio | 6.66 | ||
| Quick Ratio | 6.66 | ||
| Altman-Z | -0.31 |
F-Score6
WACC6.26%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
EPS Next Y-1%
EPS Next 2Y20.29%
EPS Next 3Y13.98%
EPS Next 5YN/A
Revenue 1Y (TTM)4.1%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%
Revenue Next Year4.4%
Revenue Next 2Y3.86%
Revenue Next 3Y3.93%
Revenue Next 5YN/A
EBIT growth 1Y46.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year371.18%
EBIT Next 3Y72.66%
EBIT Next 5YN/A
FCF growth 1Y38.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.8%
OCF growth 3YN/A
OCF growth 5Y-15.84%
DIVERSIFIED HEALTHCARE TRUST / DHC FAQ
What is the fundamental rating for DHC stock?
ChartMill assigns a fundamental rating of 2 / 10 to DHC.
What is the valuation status for DHC stock?
ChartMill assigns a valuation rating of 1 / 10 to DIVERSIFIED HEALTHCARE TRUST (DHC). This can be considered as Overvalued.
How profitable is DIVERSIFIED HEALTHCARE TRUST (DHC) stock?
DIVERSIFIED HEALTHCARE TRUST (DHC) has a profitability rating of 1 / 10.
What is the expected EPS growth for DIVERSIFIED HEALTHCARE TRUST (DHC) stock?
The Earnings per Share (EPS) of DIVERSIFIED HEALTHCARE TRUST (DHC) is expected to decline by -1% in the next year.